<?xml version="1.0" encoding="UTF-8"?>
<!-- This sitemap was dynamically generated on November 21, 2026 at 10:10 pm by All in One SEO v5.0.5.1 - the original SEO plugin for WordPress. -->

<?xml-stylesheet type="text/xsl" href="https://helixgatebiotechreview.com/default-sitemap.xsl"?>

<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
	<channel>
		<title>Helixgate</title>
		<link><![CDATA[https://helixgatebiotechreview.com]]></link>
		<description><![CDATA[Helixgate]]></description>
		<lastBuildDate><![CDATA[Sat, 21 Nov 2026 21:56:35 +0000]]></lastBuildDate>
		<docs>https://validator.w3.org/feed/docs/rss2.html</docs>
		<atom:link href="https://helixgatebiotechreview.com/sitemap.rss" rel="self" type="application/rss+xml" />
		<ttl><![CDATA[60]]></ttl>

		<item>
			<guid><![CDATA[http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/breckenridge-pharmaceutical-inc-issues-voluntary-nationwide-consumer-level-recall-one-lot]]></guid>
			<link><![CDATA[http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/breckenridge-pharmaceutical-inc-issues-voluntary-nationwide-consumer-level-recall-one-lot]]></link>
			<title>Breckenridge Pharmaceutical, Inc. Issues Voluntary Nationwide Consumer-Level Recall of One Lot of Propranolol Hydrochloride Extended-Release Capsules, USP, 60 mg, Due to Potential Metal Contamination</title>
			<pubDate><![CDATA[Sat, 21 Nov 2026 21:56:35 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/greenwich-rx-issues-voluntary-nationwide-recall-compounded-sterile-products-due-lack-sterility]]></guid>
			<link><![CDATA[http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/greenwich-rx-issues-voluntary-nationwide-recall-compounded-sterile-products-due-lack-sterility]]></link>
			<title>Greenwich Rx Issues Voluntary Nationwide Recall  of Compounded Sterile Products Due to Lack of Sterility Assurance</title>
			<pubDate><![CDATA[Sat, 21 Nov 2026 21:56:28 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.biospace.com/drug-development/CTAD-2026-bms-cobenfy-eases-alzheimer&apos;s-psychosis-as-expected-but-safety-events-raise-questions]]></guid>
			<link><![CDATA[https://www.biospace.com/drug-development/CTAD-2026-bms-cobenfy-eases-alzheimer&apos;s-psychosis-as-expected-but-safety-events-raise-questions]]></link>
			<title>CTAD 2026: BMS’ Cobenfy eases Alzheimer’s psychosis as expected but safety events raise questions</title>
			<pubDate><![CDATA[Sat, 21 Nov 2026 14:56:20 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://bioengineer.org/beat-aml-precision-trial-marks-decade-of-genomic-matching-and-extended-survival/]]></guid>
			<link><![CDATA[https://bioengineer.org/beat-aml-precision-trial-marks-decade-of-genomic-matching-and-extended-survival/]]></link>
			<title>Beat AML Precision Trial Marks Decade of Genomic Matching and Extended Survival</title>
			<pubDate><![CDATA[Sat, 21 Nov 2026 14:18:21 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://bio.news/state-policy/maryland-backs-upper-payment-limits-as-other-states-have-second-thoughts-on-pdabs/]]></guid>
			<link><![CDATA[https://bio.news/state-policy/maryland-backs-upper-payment-limits-as-other-states-have-second-thoughts-on-pdabs/]]></link>
			<title>Maryland backs upper payment limits as other states have second thoughts on PDABs</title>
			<pubDate><![CDATA[Sat, 21 Nov 2026 13:56:08 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://pharmaphorum.com/news/sanofi-reported-be-looking-insmed-takeover]]></guid>
			<link><![CDATA[https://pharmaphorum.com/news/sanofi-reported-be-looking-insmed-takeover]]></link>
			<title>Sanofi reported to be looking at an Insmed takeover</title>
			<pubDate><![CDATA[Sat, 21 Nov 2026 12:03:23 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://pharmaphorum.com/news/macmillan-lends-support-uk-prostate-cancer-data-project]]></guid>
			<link><![CDATA[https://pharmaphorum.com/news/macmillan-lends-support-uk-prostate-cancer-data-project]]></link>
			<title>Macmillan lends support to UK prostate cancer data project</title>
			<pubDate><![CDATA[Sat, 21 Nov 2026 12:03:22 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.genengnews.com/topics/drug-discovery/type-1-diabetes-delayed-in-mice-by-stem-cell-derived-vesicles-that-calm-immune-response/]]></guid>
			<link><![CDATA[https://www.genengnews.com/topics/drug-discovery/type-1-diabetes-delayed-in-mice-by-stem-cell-derived-vesicles-that-calm-immune-response/]]></link>
			<title>Type 1 Diabetes Delayed in Mice by Stem Cell-Derived Vesicles That Calm Immune Response</title>
			<pubDate><![CDATA[Sat, 21 Nov 2026 11:32:14 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.genengnews.com/topics/artificial-intelligence/former-verily-leaders-build-ai-platform-to-get-more-from-proteomics-data/]]></guid>
			<link><![CDATA[https://www.genengnews.com/topics/artificial-intelligence/former-verily-leaders-build-ai-platform-to-get-more-from-proteomics-data/]]></link>
			<title>Former Verily Leaders Build AI Platform to Get More from Proteomics Data</title>
			<pubDate><![CDATA[Sat, 21 Nov 2026 11:32:13 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.genengnews.com/topics/genome-editing/genome-writing-inserts-human-x-linked-disease-dna-into-mice/]]></guid>
			<link><![CDATA[https://www.genengnews.com/topics/genome-editing/genome-writing-inserts-human-x-linked-disease-dna-into-mice/]]></link>
			<title>Genome Writing Inserts Human X-Linked Disease DNA Into Mice</title>
			<pubDate><![CDATA[Sat, 21 Nov 2026 11:32:12 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.biospace.com/drug-development/CTAD-2026-bms-cobenfy-eases-alzheimer&apos;s-psychosis-as-expected-but-safety-events-raise-questions]]></guid>
			<link><![CDATA[https://www.biospace.com/drug-development/CTAD-2026-bms-cobenfy-eases-alzheimer&apos;s-psychosis-as-expected-but-safety-events-raise-questions]]></link>
			<title>CTAD 2026: BMS’ Cobenfy eases Alzheimer’s psychosis as expected but safety events raise questions</title>
			<pubDate><![CDATA[Sat, 21 Nov 2026 08:28:50 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.biospace.com/drug-development/merck-kelun-adc-scores-survival-win-in-phase-3-gastroesophageal-cancer-trial]]></guid>
			<link><![CDATA[https://www.biospace.com/drug-development/merck-kelun-adc-scores-survival-win-in-phase-3-gastroesophageal-cancer-trial]]></link>
			<title>Merck-Kelun ADC scores survival win in Phase 3 gastroesophageal cancer trial</title>
			<pubDate><![CDATA[Sat, 21 Nov 2026 08:28:49 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.biospace.com/business/an-insmed-takeout-by-sanofi-would-be-clear-strategic-fit-in-respiratory-space]]></guid>
			<link><![CDATA[https://www.biospace.com/business/an-insmed-takeout-by-sanofi-would-be-clear-strategic-fit-in-respiratory-space]]></link>
			<title>An Insmed takeout by Sanofi would be ‘clear strategic fit’ in respiratory space</title>
			<pubDate><![CDATA[Sat, 21 Nov 2026 08:28:47 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.biospace.com/drug-development/revmed-pads-rasonques-first-line-survival-advantage-in-pancreatic-cancer-with-early-data]]></guid>
			<link><![CDATA[https://www.biospace.com/drug-development/revmed-pads-rasonques-first-line-survival-advantage-in-pancreatic-cancer-with-early-data]]></link>
			<title>RevMed pads Rasonque’s first-line survival advantage in pancreatic cancer with early data</title>
			<pubDate><![CDATA[Sat, 21 Nov 2026 08:28:46 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.biospace.com/fda/fda-will-miss-rare-decision-deadline-for-savara-candidate-after-three-month-delay]]></guid>
			<link><![CDATA[https://www.biospace.com/fda/fda-will-miss-rare-decision-deadline-for-savara-candidate-after-three-month-delay]]></link>
			<title>FDA will miss rare decision deadline for Savara candidate after three-month delay</title>
			<pubDate><![CDATA[Sat, 21 Nov 2026 08:28:44 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.statnews.com/2026/11/20/fda-rejects-capricor-duchenne-therapy/?utm_campaign=rss]]></guid>
			<link><![CDATA[https://www.statnews.com/2026/11/20/fda-rejects-capricor-duchenne-therapy/?utm_campaign=rss]]></link>
			<title>STAT+: FDA rejects Capricor Therapeutics’ Duchenne therapy, a decision that was a long time coming</title>
			<pubDate><![CDATA[Sat, 21 Nov 2026 07:48:23 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.biocentury.com/article/661619/marrow-delivering-sirna-to-bone-marrow?utm_source=bc_rss&amp;utm_medium=rss]]></guid>
			<link><![CDATA[https://www.biocentury.com/article/661619/marrow-delivering-sirna-to-bone-marrow?utm_source=bc_rss&amp;utm_medium=rss]]></link>
			<title>Marrow: Delivering siRNA to bone marrow</title>
			<pubDate><![CDATA[Sat, 21 Nov 2026 07:08:11 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.biocentury.com/article/661677/innovation-radar-where-to-intervene-in-neutrophil-extracellular-traps?utm_source=bc_rss&amp;utm_medium=rss]]></guid>
			<link><![CDATA[https://www.biocentury.com/article/661677/innovation-radar-where-to-intervene-in-neutrophil-extracellular-traps?utm_source=bc_rss&amp;utm_medium=rss]]></link>
			<title>Innovation Radar:  Where to intervene in neutrophil extracellular traps</title>
			<pubDate><![CDATA[Sat, 21 Nov 2026 07:08:08 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.biocentury.com/article/661548/private-european-biopharmas-make-bigger-acquisitions-in-2026?utm_source=bc_rss&amp;utm_medium=rss]]></guid>
			<link><![CDATA[https://www.biocentury.com/article/661548/private-european-biopharmas-make-bigger-acquisitions-in-2026?utm_source=bc_rss&amp;utm_medium=rss]]></link>
			<title>Private European biopharmas make bigger acquisitions in 2026</title>
			<pubDate><![CDATA[Sat, 21 Nov 2026 07:08:00 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.biocentury.com/article/661702/flagship-pours-100m-into-new-u-k-company-creation-lab?utm_source=bc_rss&amp;utm_medium=rss]]></guid>
			<link><![CDATA[https://www.biocentury.com/article/661702/flagship-pours-100m-into-new-u-k-company-creation-lab?utm_source=bc_rss&amp;utm_medium=rss]]></link>
			<title>Flagship pours £100M into new U.K. company creation lab</title>
			<pubDate><![CDATA[Sat, 21 Nov 2026 07:07:58 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.biocentury.com/article/661706/aribio-s-split-phase-iii-result-reflects-a-mixed-ctad?utm_source=bc_rss&amp;utm_medium=rss]]></guid>
			<link><![CDATA[https://www.biocentury.com/article/661706/aribio-s-split-phase-iii-result-reflects-a-mixed-ctad?utm_source=bc_rss&amp;utm_medium=rss]]></link>
			<title>AriBio’s split Phase III result reflects a mixed CTAD</title>
			<pubDate><![CDATA[Sat, 21 Nov 2026 07:07:56 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.biocentury.com/article/661670/biotech-will-find-a-way-the-coins-act-won-t-stop-china-biotech-innovation?utm_source=bc_rss&amp;utm_medium=rss]]></guid>
			<link><![CDATA[https://www.biocentury.com/article/661670/biotech-will-find-a-way-the-coins-act-won-t-stop-china-biotech-innovation?utm_source=bc_rss&amp;utm_medium=rss]]></link>
			<title>Biotech will find a way: The COINS Act won’t stop China biotech innovation</title>
			<pubDate><![CDATA[Sat, 21 Nov 2026 07:07:52 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.biopharmadive.com/news/biotech-china-deals-venture-returns-summit-stock/874912/]]></guid>
			<link><![CDATA[https://www.biopharmadive.com/news/biotech-china-deals-venture-returns-summit-stock/874912/]]></link>
			<title>This week in charts: Biotech investors’ China bets are already paying off</title>
			<pubDate><![CDATA[Sat, 21 Nov 2026 02:29:50 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.biopharmadive.com/news/celldex-eczema-nchroma-layoffs-isomorphic-merck-teva-vitrivax/875241/]]></guid>
			<link><![CDATA[https://www.biopharmadive.com/news/celldex-eczema-nchroma-layoffs-isomorphic-merck-teva-vitrivax/875241/]]></link>
			<title>Celldex drug stumbles in eczema; Epigenetic editing startup cuts staff</title>
			<pubDate><![CDATA[Sat, 21 Nov 2026 02:29:49 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.biopharmadive.com/news/erasca-kras-pancreatic-cancer-drug-results-revolution-rasonque/875314/]]></guid>
			<link><![CDATA[https://www.biopharmadive.com/news/erasca-kras-pancreatic-cancer-drug-results-revolution-rasonque/875314/]]></link>
			<title>Erasca data add to pressure facing Revolution’s breakthrough cancer drug</title>
			<pubDate><![CDATA[Sat, 21 Nov 2026 02:29:48 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.biopharmadive.com/news/race-first-psilocybin-blockbuster-compass-usona/875369/]]></guid>
			<link><![CDATA[https://www.biopharmadive.com/news/race-first-psilocybin-blockbuster-compass-usona/875369/]]></link>
			<title>Will the first approved psychedelic become a blockbuster?</title>
			<pubDate><![CDATA[Sat, 21 Nov 2026 02:29:47 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://phys.org/news/2026-11-optical-dna-yeast-genomes-chromosome.html]]></guid>
			<link><![CDATA[https://phys.org/news/2026-11-optical-dna-yeast-genomes-chromosome.html]]></link>
			<title>Optical DNA mapping assembles yeast genomes at chromosome scale</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 22:01:13 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.pharmavoice.com/news/race-first-psilocybin-blockbuster-compass-usona/875270/]]></guid>
			<link><![CDATA[https://www.pharmavoice.com/news/race-first-psilocybin-blockbuster-compass-usona/875270/]]></link>
			<title>Will the first approved psychedelic become a blockbuster?</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 20:59:13 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.labiotech.eu/partner/ai-antibody-design-validation/]]></guid>
			<link><![CDATA[https://www.labiotech.eu/partner/ai-antibody-design-validation/]]></link>
			<title>Two days in cell-free, three days in CHO: antibody sequence to data with Biointron’s RushDATA&#x2122;</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 17:43:42 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.statnews.com/2026/11/20/biotech-news-early-results-for-alterome-kras-drug-arrive/?utm_campaign=rss]]></guid>
			<link><![CDATA[https://www.statnews.com/2026/11/20/biotech-news-early-results-for-alterome-kras-drug-arrive/?utm_campaign=rss]]></link>
			<title>STAT+: Early results for Alterome’s KRAS drug for pancreas, lung and colon cancer arrive</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 16:56:36 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.biospace.com/biospace-layoff-tracker]]></guid>
			<link><![CDATA[https://www.biospace.com/biospace-layoff-tracker]]></link>
			<title>As part of sales reorganization, Novo will cut 215 employees at US HQ</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 15:14:00 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[http://www.fda.gov/drugs/nda-and-bla-approvals/accelerated-approval-program]]></guid>
			<link><![CDATA[http://www.fda.gov/drugs/nda-and-bla-approvals/accelerated-approval-program]]></link>
			<title>Accelerated Approval Program</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 14:50:54 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[http://www.fda.gov/drugs/accelerated-approval-program/ongoing-non-malignant-hematological-neurological-and-other-disorder-indications-accelerated]]></guid>
			<link><![CDATA[http://www.fda.gov/drugs/accelerated-approval-program/ongoing-non-malignant-hematological-neurological-and-other-disorder-indications-accelerated]]></link>
			<title>Ongoing | Non-malignant Hematological, Neurological, and Other Disorder Indications Accelerated Approvals</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 14:50:52 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[http://www.fda.gov/drugs/drug-alerts-and-statements/fda-publishes-new-batch-product-specific-guidances-facilitate-generic-drug-development]]></guid>
			<link><![CDATA[http://www.fda.gov/drugs/drug-alerts-and-statements/fda-publishes-new-batch-product-specific-guidances-facilitate-generic-drug-development]]></link>
			<title>FDA Publishes New Batch of Product-Specific Guidances to Facilitate Generic Drug Development</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 14:50:32 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[http://www.fda.gov/drugs/guidances-drugs/upcoming-product-specific-guidances-generic-drug-product-development]]></guid>
			<link><![CDATA[http://www.fda.gov/drugs/guidances-drugs/upcoming-product-specific-guidances-generic-drug-product-development]]></link>
			<title>Upcoming Product-Specific Guidances for Generic Drug Product Development</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 14:50:29 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[http://www.fda.gov/drugs/accelerated-approval-program/verified-clinical-benefit-non-malignant-hematological-neurological-and-other-disorder-indications]]></guid>
			<link><![CDATA[http://www.fda.gov/drugs/accelerated-approval-program/verified-clinical-benefit-non-malignant-hematological-neurological-and-other-disorder-indications]]></link>
			<title>Verified Clinical Benefit | Non-malignant Hematological, Neurological, and Other Disorder Indications Accelerated Approvals</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 14:49:52 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[http://www.fda.gov/drugs/development-resources/written-requests-issued-pediatric-studies]]></guid>
			<link><![CDATA[http://www.fda.gov/drugs/development-resources/written-requests-issued-pediatric-studies]]></link>
			<title>Written Requests Issued for Pediatric Studies</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 14:49:45 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[http://www.fda.gov/drugs/development-resources/pediatric-exclusivity-granted]]></guid>
			<link><![CDATA[http://www.fda.gov/drugs/development-resources/pediatric-exclusivity-granted]]></link>
			<title>Pediatric Exclusivity Granted</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 14:49:41 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[http://www.fda.gov/drugs/drug-approvals-and-databases/drugsfda-data-files]]></guid>
			<link><![CDATA[http://www.fda.gov/drugs/drug-approvals-and-databases/drugsfda-data-files]]></link>
			<title>Drugs@FDA Data Files</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 14:46:17 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.statnews.com/pharmalot/2026/11/19/merck-isomorphic-ai-deal-china-pharmaceutical-supply-chain/?utm_campaign=rss]]></guid>
			<link><![CDATA[https://www.statnews.com/pharmalot/2026/11/19/merck-isomorphic-ai-deal-china-pharmaceutical-supply-chain/?utm_campaign=rss]]></link>
			<title>STAT+: Pharmalittle: We’re reading about a Merck AI deal, China and the pharma supply chain, and more</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 14:39:30 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.statnews.com/pharmalot/2026/11/19/china-pharma-biotech-clinical-trials-security-risk-patents-drug-development/?utm_campaign=rss]]></guid>
			<link><![CDATA[https://www.statnews.com/pharmalot/2026/11/19/china-pharma-biotech-clinical-trials-security-risk-patents-drug-development/?utm_campaign=rss]]></link>
			<title>STAT+: Big drugmakers tell House committee they will halt clinical trials at some hospitals in China</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 14:39:29 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.statnews.com/2026/11/19/maha-pac-midterm-election-spending-fda-questions-after-heidi-overton/?utm_campaign=rss]]></guid>
			<link><![CDATA[https://www.statnews.com/2026/11/19/maha-pac-midterm-election-spending-fda-questions-after-heidi-overton/?utm_campaign=rss]]></link>
			<title>STAT+: MAHA PAC’s steakhouse spend</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 14:39:29 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.statnews.com/pharmalot/2026/11/20/sanofi-eyeing-insmed-ai-speeding-drug-development/?utm_campaign=rss]]></guid>
			<link><![CDATA[https://www.statnews.com/pharmalot/2026/11/20/sanofi-eyeing-insmed-ai-speeding-drug-development/?utm_campaign=rss]]></link>
			<title>STAT+: Pharmalittle: We’re reading about Sanofi eyeing Insmed, AI speeding drug development, and more</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 14:39:27 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[http://www.fda.gov/about-fda/office-health-advancement/office-health-advancement-oha-guidance-documents]]></guid>
			<link><![CDATA[http://www.fda.gov/about-fda/office-health-advancement/office-health-advancement-oha-guidance-documents]]></link>
			<title>Office of Health Advancement (OHA) Guidance Documents</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 13:09:38 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/medical-device-correction-update-lunar-g3-bpap-system-model-lg3800-30vt]]></guid>
			<link><![CDATA[http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/medical-device-correction-update-lunar-g3-bpap-system-model-lg3800-30vt]]></link>
			<title>Medical Device Correction Update  Luna® G3 BPAP System (Model LG3800-30VT)</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 11:24:58 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.biospace.com/drug-development/CTAD-2026-bms-cobenfy-eases-alzheimer&apos;s-psychosis-as-expected-but-safety-events-raise-questions]]></guid>
			<link><![CDATA[https://www.biospace.com/drug-development/CTAD-2026-bms-cobenfy-eases-alzheimer&apos;s-psychosis-as-expected-but-safety-events-raise-questions]]></link>
			<title>CTAD 2026: BMS’ Cobenfy eases Alzheimer’s psychosis as expected but safety events raise questions</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 06:39:16 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://bioengineer.org/routine-psa-machine-learning-model-improves-prostate-cancer-triage-in-multicenter-study/]]></guid>
			<link><![CDATA[https://bioengineer.org/routine-psa-machine-learning-model-improves-prostate-cancer-triage-in-multicenter-study/]]></link>
			<title>Routine PSA Machine Learning Model Improves Prostate Cancer Triage in Multicenter Study</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 06:00:50 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://bioengineer.org/genotype-d1-hepatitis-b-virus-protein-mutations-follow-phase-dependent-structural-shifts/]]></guid>
			<link><![CDATA[https://bioengineer.org/genotype-d1-hepatitis-b-virus-protein-mutations-follow-phase-dependent-structural-shifts/]]></link>
			<title>Genotype D1 Hepatitis B Virus Protein Mutations Follow Phase-Dependent Structural Shifts</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 06:00:15 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://bioengineer.org/case-study-analyzes-recurrent-obstructing-nipple-duct-stones-in-two-lactating-patients/]]></guid>
			<link><![CDATA[https://bioengineer.org/case-study-analyzes-recurrent-obstructing-nipple-duct-stones-in-two-lactating-patients/]]></link>
			<title>Case Study Analyzes Recurrent Obstructing Nipple Duct Stones in Two Lactating Patients</title>
			<pubDate><![CDATA[Fri, 20 Nov 2026 05:59:11 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://helixgatebiotechreview.com/]]></guid>
			<link><![CDATA[https://helixgatebiotechreview.com/]]></link>
			<title>Home</title>
			<pubDate><![CDATA[Mon, 07 Sep 2026 03:39:54 +0000]]></pubDate>
		</item>
				</channel>
</rss>
